Research ExplorerPublicationsAntigen-specific targeting and elimination of EBV-transforme...

Antigen-specific targeting and elimination of EBV-transformed B cells by allergen toxins.

Standard

Antigen-specific targeting and elimination of EBV-transformed B cells by allergen toxins. / Stöcker, Michael; Klockenbring, Torsten; Huhn, Michael; Nachreiner, Thomas; Wicklein, Daniel; Petersen, Arnd; Bauer, Ralf; Goerlich, Roland; Fischer, Rainer; Barth, Stefan.

In: J ALLERGY CLIN IMMUN, Vol. 116, No. 4, 4, 2005, p. 910-915.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Stöcker, M, Klockenbring, T, Huhn, M, Nachreiner, T, Wicklein, D, Petersen, A, Bauer, R, Goerlich, R, Fischer, R & Barth, S 2005, 'Antigen-specific targeting and elimination of EBV-transformed B cells by allergen toxins.', J ALLERGY CLIN IMMUN, vol. 116, no. 4, 4, pp. 910-915. <http://www.ncbi.nlm.nih.gov/pubmed/16210069?dopt=Citation>

APA

Stöcker, M., Klockenbring, T., Huhn, M., Nachreiner, T., Wicklein, D., Petersen, A., Bauer, R., Goerlich, R., Fischer, R., & Barth, S. (2005). Antigen-specific targeting and elimination of EBV-transformed B cells by allergen toxins. J ALLERGY CLIN IMMUN, 116(4), 910-915. [4]. http://www.ncbi.nlm.nih.gov/pubmed/16210069?dopt=Citation

Vancouver

Stöcker M, Klockenbring T, Huhn M, Nachreiner T, Wicklein D, Petersen A et al. Antigen-specific targeting and elimination of EBV-transformed B cells by allergen toxins. J ALLERGY CLIN IMMUN. 2005;116(4):910-915. 4.

Bibtex

@article{851fc937f561473fa76854d575073b1a,
title = "Antigen-specific targeting and elimination of EBV-transformed B cells by allergen toxins.",
abstract = "With the exception of antigen-specific immunotherapy, current treatments for atopic diseases provide only symptomatic relief. Because of the increasing incidence of such diseases, the development of novel strategies and concepts for the treatment of allergies is urgently needed.",
keywords = "Humans, Cytotoxicity, Immunologic, *Allergens/genetics/immunology, B-Lymphocytes/*immunology/*virology, Cell Transformation, Viral, Herpesvirus 4, Human/*immunology, Hypersensitivity, Immediate/*immunology/therapy, Immunotoxins/genetics/immunology/*pharmacology, Phleum/genetics/immunology, Plant Proteins/genetics/immunology, Recombinant Fusion Proteins/genetics/immunology/*pharmacology, Ribonucleases/genetics/immunology, Humans, Cytotoxicity, Immunologic, *Allergens/genetics/immunology, B-Lymphocytes/*immunology/*virology, Cell Transformation, Viral, Herpesvirus 4, Human/*immunology, Hypersensitivity, Immediate/*immunology/therapy, Immunotoxins/genetics/immunology/*pharmacology, Phleum/genetics/immunology, Plant Proteins/genetics/immunology, Recombinant Fusion Proteins/genetics/immunology/*pharmacology, Ribonucleases/genetics/immunology",
author = "Michael St{\"o}cker and Torsten Klockenbring and Michael Huhn and Thomas Nachreiner and Daniel Wicklein and Arnd Petersen and Ralf Bauer and Roland Goerlich and Rainer Fischer and Stefan Barth",
year = "2005",
language = "English",
volume = "116",
pages = "910--915",
journal = "J ALLERGY CLIN IMMUN",
issn = "0091-6749",
publisher = "Mosby Inc.",
number = "4",

}

RIS

TY - JOUR

T1 - Antigen-specific targeting and elimination of EBV-transformed B cells by allergen toxins.

AU - Stöcker, Michael

AU - Klockenbring, Torsten

AU - Huhn, Michael

AU - Nachreiner, Thomas

AU - Wicklein, Daniel

AU - Petersen, Arnd

AU - Bauer, Ralf

AU - Goerlich, Roland

AU - Fischer, Rainer

AU - Barth, Stefan

PY - 2005

Y1 - 2005

N2 - With the exception of antigen-specific immunotherapy, current treatments for atopic diseases provide only symptomatic relief. Because of the increasing incidence of such diseases, the development of novel strategies and concepts for the treatment of allergies is urgently needed.

AB - With the exception of antigen-specific immunotherapy, current treatments for atopic diseases provide only symptomatic relief. Because of the increasing incidence of such diseases, the development of novel strategies and concepts for the treatment of allergies is urgently needed.

KW - Humans

KW - Cytotoxicity, Immunologic

KW - Allergens/genetics/immunology

KW - B-Lymphocytes/immunology/virology

KW - Cell Transformation, Viral

KW - Herpesvirus 4, Human/immunology

KW - Hypersensitivity, Immediate/immunology/therapy

KW - Immunotoxins/genetics/immunology/pharmacology

KW - Phleum/genetics/immunology

KW - Plant Proteins/genetics/immunology

KW - Recombinant Fusion Proteins/genetics/immunology/pharmacology

KW - Ribonucleases/genetics/immunology

KW - Humans

KW - Cytotoxicity, Immunologic

KW - Allergens/genetics/immunology

KW - B-Lymphocytes/immunology/virology

KW - Cell Transformation, Viral

KW - Herpesvirus 4, Human/immunology

KW - Hypersensitivity, Immediate/immunology/therapy

KW - Immunotoxins/genetics/immunology/pharmacology

KW - Phleum/genetics/immunology

KW - Plant Proteins/genetics/immunology

KW - Recombinant Fusion Proteins/genetics/immunology/pharmacology

KW - Ribonucleases/genetics/immunology

M3 - SCORING: Journal article

VL - 116

SP - 910

EP - 915

JO - J ALLERGY CLIN IMMUN

JF - J ALLERGY CLIN IMMUN

SN - 0091-6749

IS - 4

M1 - 4

ER -